header logo image


Page 984«..1020..983984985986..9901,000..»

Camp for children with arthritis gets visited by NFL player – KTBS

June 18th, 2017 1:41 am

Shreveport, LA -- Juvenile Arthritis is a condition no child and their family should have to go through.

That's why rheumatoid arthritis doctor Tom Pressly started Jambalaya Jubilee to help children and the families get the latest on medicine in their field and also meet others like themselves. The children also get to do fun activities at the family retreat together like arts and craft, bowling, and visiting facilities like Sci-Port.

This year is the 27th annual Jambalaya Jubilee and 44 families were a part of the program.

Saturday morning, they were visited by Kansas City Chiefs player Charcandrick West who also had juvenile rheumatoid arthritis. He says he was once bedridden by the pain, but Dr. Pressly helped him find a cure.

Today West told the children in the camp that no dream is too big for them and that they shouldn't let anyone discourage them from following it.

West says it's a blessing for him to be able to meet with the kids and see them fight their illness.

Both West and Dr. Presssly hope the camp encourages the children to lead their lives and follow their dreams. Pressly also hopes families see that they aren't alone in their struggle and their children can still lead normal lives.

See original here:
Camp for children with arthritis gets visited by NFL player - KTBS

Read More...

Should You Give Your Pet Medical Marijuana For Arthritis? – The Alternative Daily (blog)

June 18th, 2017 1:41 am

While much of the Western world is only just beginning to embrace the notion of medical marijuana for humans, theres an even more controversial debate lurking right around the corner hasanyone thought about giving their pet a strong dose of pot?

Immediately, images of dogs with great big marijuana joints hanging out of their mouths jump into your mind. Or perhaps a cute little kitten taking a good long drag on a bong and going into a fit of cute kitten coughs. While its a slightly hilarious mental picture, its obviously not accurate how the heck would you get them to inhale the smoke anyway? Smoke a joint yourself and blow it into their face?

But beyond the practical (and ethical) dilemma such a scene represents, theres another reason why your pet isnt going to be ingesting marijuana: its not marijuana that theyre ingesting! Not the kind that you became familiar with in your rebellious teenage years, anyway.

Hemp contains CBD, responsible for multiple health-promoting effects.

Lets get one thing straight: hemp and marijuana are, indeed, the same species. Theres actually a lot of misconceptions surrounding what exactly hemp is, with many people thinking theyre either completely separate species, or that hemp is the male variety of Cannabis sativa and marijuana the female.

The truth is, hemp and marijuana are simply different cultivars of the exact same species. While marijuana contains high levels of THC, the cannabinoid that creates that mind-altering high, hemp is required by law to have a THC concentration of 0.3 percent or less. Also, depending on the specific cultivar, hemp often contains higher levels of the therapeutic active compound cannabidiol (CBD), which is responsible for almost all of Cannabis sativas health-promoting effects.

For this reason, most of the cannabis products on the market aimed at pets are in fact hemp, as this still elicits the therapeutic effects on your pet but doesnt get them staring vacantly at the TV or eating everything in sight. The exception, of course, is those products specifically formulated for treating pet anxiety. In this case, a strong dose of THC from good old marijuana is just the ticket.

The short answer is: maybe. Theres a growing body of evidence to confirm that medical marijuana (and indeed hemp) has a huge range of beneficial effects on the body and mind of us humans. You can take your pick of the therapeutic powers of marijuana: cancer treatment, pain-alleviating, reduction in multiple sclerosis symptoms, epilepsy treatment and of course as an antidepressant.

And while our physiology may differ considerably from that of our pets, there are enough similarities to confirm that many of these same therapeutic effects of marijuana can also be experienced by our animals. Unfortunately, because its an emerging field, theres not as much scientific evidence as one would like. But, what studies have been completed show a lot of promise. And there are the thousands of anecdotal case studies from pet owners all over the world to consider.

But before we dive any deeper, its important to emphasize that every pet is different. As you well know, they come in all shapes and sizes, from tiny little birds to Great Danes or even horses. For each species and indeed each breed, the dosage is always going to be different, meaning you should consult your vet before starting your problematic pet on a course of cannabis.

So, why should you give your pet marijuana to treat his or her health problems? Lets find out.

Multiple studies have shown that CBD can treat arthritis, and it may be true for your pet too.

Many holistic vets across the country are recommending medical marijuana for the treatment of arthritis in certain animals, including cats and dogs. They maintain that the potent anti-inflammatory compounds in marijuana and hemp, largely in the form of CBD, can provide significant relief from pain in arthritic pets and enable them to have fuller, more enjoyable lives.

And theres plenty of research out there, admittedly mostly conducted on rats and mice, that supports these veterinary claims. A study published in 2000 in the journal PNAS used a concentrated form of CBD (which youll recall is found in high concentrations in hemp, and to a lesser extent marijuana) to treat two different forms of arthritis in mice. They found that in both models of arthritis, the treatment effectively blocked progression of arthritis.

Another study, this time published in 2004, examined the therapeutic effect that CBD exhibited on rats that had been injected with inflammation-causing and arthritis-inducing carrageenan. Researchers concluded that the CBD had significant beneficial effects on many different markers of both inflammation and arthritis.

For this reason, using medical marijuana, hemp or a high-quality cannabidiol (CBD) treatment can provide good levels of relief for your pet, especially cats, dogs and (apparently) rats and mice. Combining CBD treatment with other holistic treatments, like massage, acupuncture (yup, acupuncture for pets is a thing!) and fish oil, can increase your chance of success.

Inflammatory bowel disease is a surprisingly common affliction in pets, particularly cats. By reducing inflammation, its possible that the CBD in marijuana may help to alleviate symptoms of IBS. By soothing their gastrointestinal tract, the CBD will also allow them to regain a healthy weight and be more enthusiastic about eating. Perhaps a little too enthusiastic at times!

CBD may promote feelings of calm for your anxious pet.

Just as it is in humans, anxiety is a very real problem in many pets. Our cat, Ollie, had all sorts of problems with anxiety, stemming from a very troubled kittenhood as an abandoned street cat. While we were able to soothe much of those anxieties away over years of TLC, he still suffered form serious bouts of anxiety from time to time, particularly when lightning storms rolled in across the lake. The last time this happened, he actually suffered from a complete urinary tract blockage, and we spent many hundreds of dollars and a harrowing week trying to bring him back from the brink with various drugs and anti-anxiety medications.

The CBD in medical marijuana has the ability to almost instantaneously foster feelings of tranquility and calm in pets, thereby helping them to overcome their anxiety. And while I dont recommend regular use of marijuana to calm their frayed nerves, in scenarios like our beloved Ollies case, it may be a life-saving move.

Liivi Hess

Tweet

Share

Tags: anxiety, arthritis, cannabis, cats, CBD, dogs, hemp, ibs, inflammation, marijuana, medical marijuana, pets, pot, THC, weed

Read more from the original source:
Should You Give Your Pet Medical Marijuana For Arthritis? - The Alternative Daily (blog)

Read More...

On the cusp of payoffs for patients, stem cell therapy faces threat from unregulated clinics – STAT

June 18th, 2017 1:40 am

Cancer researchers worry immunotherapy may hasten growth of tumors

Cancer researchers worry immunotherapy may hasten growth of tumors in some patients

Carbon monoxide is toxic. This doctor is out to

Carbon monoxide is toxic. This doctor is out to prove its also therapeutic

Game of Genomes Season 1: An epic quest to

Game of Genomes Season 1: An epic quest to crack the mysteries of our DNA

Coroner: Sleep apnea among causes of Carrie Fishers death

Coroner: Sleep apnea among causes of Carrie Fishers death

At first meeting of Trumps opioid commission, health advocates

At first meeting of Trumps opioid commission, health advocates plead for Medicaid spending

This bill would reinstate a controversial drug discount for

This bill would reinstate a controversial drug discount for some hospitals

View post:
On the cusp of payoffs for patients, stem cell therapy faces threat from unregulated clinics - STAT

Read More...

Research Finds Dressmakers Have Good Eyes, And Not Just For Style – NPR

June 16th, 2017 5:50 pm

In a study that tested the vision of people from a variety of professions, researchers at the University of California, Berkeley found that dressmakers who spend many hours doing fine, manual work seemed to have a superior ability to see in 3-D. Elena Fantini/Getty Images hide caption

In a study that tested the vision of people from a variety of professions, researchers at the University of California, Berkeley found that dressmakers who spend many hours doing fine, manual work seemed to have a superior ability to see in 3-D.

Julia Brennan grew up in a family of nearsighted people so nearsighted that they joked they were blind as bats. She, however, had perfect eyesight.

"Julia can see around corners," her mother would say.

Today, Brennan is a textile conservationist in Washington, D.C, and her work involves everything from fixing tiny holes in antique christening dresses to delicately stitching tears in the Brooks Brothers coat President Lincoln had with him the night he was shot.

Julia Brennan, owner of Caring for Textiles, always knew she had excellent eyesight and now wonders whether it's part of what inspired her choice of career. Courtesy of Julia Brennan hide caption

Julia Brennan, owner of Caring for Textiles, always knew she had excellent eyesight and now wonders whether it's part of what inspired her choice of career.

While her sharp eyesight is essential to her work, it was not something she thought about consciously when choosing her field. "I simply used it in one of the best professions possible," she says.

Now, a small study published this week out of the University of California, Berkeley backs up what Brennan has experienced throughout her career: Dressmakers may have superior stereoscopic vision. That's the ability to accurately perceive depth and distance between objects to see in 3-D.

Adrien Chopin, a postdoctoral researcher in visual neuroscience, made the discovery as he was testing the stereoscopic vision of about three dozen people, 13 of them dressmakers. We all use stereoscopic vision when we throw a ball to someone, grab a pencil or park a car, but Chopin noticed that some individuals have much better stereoscopic vision than others.

The testing was part of ongoing research aimed at finding ways to improve stereoscopic vision through computer games, some using virtual reality.

Chopin found that among the people in his study, dressmakers who spend a lot of time sewing by hand outperformed the study participants from other professions. The results intrigued him, given that prior studies of surgeons and dentists, who also do fine manual work, did not turn up similar results.

In fact, Chopin says, dressmakers are the only group of professionals he and his colleagues have found so far who seem to have enhanced stereoscopic vision.

Is it the endless hours of delicate, manual work that hones dressmakers' stereoscopic skills, or does the field naturally attract individuals with superior eyesight?

Chopin says further study is needed to be certain. But the findings have led him to believe there might be something unusual in the way dressmakers interact with the world.

"It's very fine manual tasks at close range, with direct feedback," he says. "If you misplace the needle just a little, you get pain. That's direct feedback on your vision."

He hopes his research might eventually help people who are stereo-impaired.

Dr. Rebecca Taylor, a Nashville ophthalmologist and the clinical spokeswoman for the American Academy of Ophthalmology, says about 10 percent of the population lacks depth perception, and one cause is poor vision in one eye. She cautions that this is not always correctable and says some problems such as amblyopia, or lazy eye, should be corrected in childhood.

Still, she thinks further study is worthwhile, given how much we use stereo vision in our daily lives. "The more information that we have about depth perception, the better we can be set up to help people who struggle with it," Taylor says.

Of course, good stereoscopic vision will only take you so far. More than 30 years into her career in textile restoration, Brennan says she now needs strong reading glasses and a good source of light to do her best work.

"I often defer to my 20- or 30-year-old colleagues to double-check a stitch or detail now," she says.

Originally posted here:
Research Finds Dressmakers Have Good Eyes, And Not Just For Style - NPR

Read More...

Crosby Lions’ new vision screening device promotes children’s eye health – Chron.com

June 16th, 2017 5:50 pm

By Melanie Feuk, mfeuk@hcnonline.com

Crosby Lions' new vision screening device promotes children's eye health

Albert Baker with the Crosby Lions Club pointed the PlusoptiX mobile vision screening camera at the child sitting across from him during the Crosby-Huffman Chamber of Commerce luncheon at Peso's Mexican Restaurant in Crosby on Thursday, June 15.

Only seconds later, the device beeped and before some people may have even realized, the demonstration was already over.

"That fast, I screened his eyes," Baker said.

The $7,000 PlusoptiX mobile vision screening camera was donated to the Crosby Lions Club two weeks ago by a fellow Crosby Lion in order to further the club's ability to perform vision screenings on children at local daycares and pre-kindergartens as a part of the Lions KidSight USA program.

"The program started about 20 years ago when we were testing children's eyes for Amblyobia, which is lazy eye," Baker said. "If you catch a child with lazy eye early, at around 1 year old, we can correct it before he or she gets into school."

Baker himself has scanned tens-of-thousands of children in the last 20 years and has firsthand experience of how important early detection of eye disease is for children.

"There was a 3-year-old girl, and I found through the old camera system that the child had a tumor in her right eye," Baker said.

Within a week, the little girl received an eye operation that saved her eyesight.

Over the course of the program, technological improvements have allowed the Lions Club to detect even more diseases in young children, thereby greatly improving the child's ability to learn and in some cases, the child's chances retaining their eyesight.

Last year, the Crosby Lions Club used a borrowed PlusoptiX camera. Now that they have their own, it will allow them to perform more vision screenings locally in Crosby, Huffman and surrounding communities.

Since the new screening device was donated, the Crosby Lions Club has done approximately 1,000 screenings.

This year is the 100th birthday of Lions International, and June 30 will mark the 92nd anniversary of Helen Keller's speech calling Lions International to be Knights of the Blind.

For more information about the Crosby Lions Club, visit the Crosby Lions Club Facebook page.

Read more:
Crosby Lions' new vision screening device promotes children's eye health - Chron.com

Read More...

After 20 years of darkness, bionic eye helps man see – WDEF News 12

June 16th, 2017 5:50 pm

After 20 years of darkness, there is light for a man in Medford, Massachusetts.

A bionic eye implant has helped Anthony Andreotolla gain back some vision. Its not eyesight in the way most people see, but the technology is making a difference in his daily life.

Anthony Andreotolla, who suffers from a degenerative eye disease, can see for the first time in 20 years thanks to a new bionic eye.

CBS Boston/WBZ-TV

Its not actual vision. Its what they call artificial vision, Andreotolla told CBS Boston.

He suffers from retinitis pigmentosa, a degenerative eye disease that affects the retina. Andreotolla began to lose his vision in his teens and by his thirties, he couldnt see anything.

Once everything is black, for many, many years, that was it, he said.

For 20 years he lived in that darkness until he became one of the first people to receive a bionic eye.

Every day, Andreotolla puts on special glasses and commutes on public transportation to his job in Boston about six miles south of his home.

A tiny camera in the glasses sends images to a wearable computer and then those images are processed and sent wirelessly to an implant in his eye. The implant surgery took place in Baltimore at The Johns Hopkins Hospital.

I dont see things the way other people do. I see everything in different flashes, lights, shapes, Andreotolla explained.

Play Video

CBSN

A blind man with a degenerative retinal disease was able to see his wife of 46 years thanks to an experimental bionic eye.

Its more of a cloudy, black and white vision, he explains.

I can tell the difference between a car or a bus or a truck. I cant tell you what make the car is, he said.

That vision helps him navigate life more safely.

After his commute, he arrives at his job as a substance abuse counselor at St. Anthony Shrine.

I have my hope back. Once I lost my sight I was resigned to be blind for the rest of my life. Im not resigned to that anymore. I believe if I can live long enough, Ill be able to see a lot of beautiful things, Andreotolla said.

The developer of the bionic eye isSecond Sightand theyre already working on the next generation of bionic eye with faster processing and sharper images.

2017 CBS Interactive Inc. All Rights Reserved.

2017 CBS Interactive Inc.

View post:
After 20 years of darkness, bionic eye helps man see - WDEF News 12

Read More...

Game used to test children’s eyesight made in Wales – BBC News

June 16th, 2017 5:50 pm

BBC News
Game used to test children's eyesight made in Wales
BBC News
A game for tablets is being developed in Wales which parents can use to test their children's eyesight at home. The Space Vision app gets children to tap increasing faint black and white squares on a grey background to make aliens pop up and make a noise.

and more »

See original here:
Game used to test children's eyesight made in Wales - BBC News

Read More...

After 20 years of darkness, bionic eye helps blind man see – CBS News

June 16th, 2017 5:50 pm

After 20 years of darkness, there is light for a man in Medford, Massachusetts.

A bionic eye implant has helped Anthony Andreotolla gain back some vision. It's not eyesight in the way most people see, but the technology is making a difference in his daily life.

Anthony Andreotolla, who suffers from a degenerative eye disease, can see for the first time in 20 years thanks to a new bionic eye.

CBS Boston/WBZ-TV

"It's not actual vision. It's what they call artificial vision," Andreotolla told CBS Boston.

He suffers from retinitis pigmentosa, a degenerative eye disease that affects the retina. Andreotolla began to lose his vision in his teens and by his thirties, he couldn't see anything.

"Once everything is black, for many, many years, that was it," he said.

For 20 years he lived in that darkness until he became one of the first people to receive a bionic eye.

Every day, Andreotolla puts on special glasses and commutes on public transportation to his job in Boston about six miles south of his home.

A tiny camera in the glasses sends images to a wearable computer and then those images are processed and sent wirelessly to an implant in his eye. The implant surgery took place in Baltimore at The Johns Hopkins Hospital.

"I don't see things the way other people do. I see everything in different flashes, lights, shapes," Andreotolla explained.

Play Video

A blind man with a degenerative retinal disease was able to see his wife of 46 years thanks to an experimental bionic eye.

It's more of a cloudy, black and white vision, he explains.

"I can tell the difference between a car or a bus or a truck. I can't tell you what make the car is," he said.

That vision helps him navigate life more safely.

After his commute, he arrives at his job as a substance abuse counselor at St. Anthony Shrine.

"I have my hope back. Once I lost my sight I was resigned to be blind for the rest of my life. I'm not resigned to that anymore. I believe if I can live long enough, I'll be able to see a lot of beautiful things," Andreotolla said.

The developer of the bionic eye isSecond Sightand they're already working on the next generation of bionic eye with faster processing and sharper images.

2017 CBS Interactive Inc. All Rights Reserved.

More:
After 20 years of darkness, bionic eye helps blind man see - CBS News

Read More...

Driving for change – AOP

June 16th, 2017 5:50 pm

High profile fatalities caused by poor eyesight have put driving and vision in the spotlight. OT explores what the UK can learn from its neighbours

16 Jun 2017 by Selina Powell

But often the conversations that are held on a national level after a fatal and potentially avoidable accident caused by poor eyesight follow a similar theme.

There are frequently calls for more stringent regulation of medical fitness to drive to prevent further accidents from occurring.

Particularly when there were red flags that a motorist's sight was failing, members of the public question why nothing was done to stop a driver from getting behind the wheel.

It is a nuanced area and one that does not have any easy answers. But asking the questions around vision and driving is increasingly important as the prevalence of vision issues among drivers increases with an ageing population.

One approach to strengthening the regulation of vision and driving in the UK is to look beyond national boundaries.

Anecdotal differences between member states prompted the European Council of Optometry and Optics (ECOO) to produce the Visual Standards for Driving in Europe report, which was published at the beginning of this year.

The report profiles how each member state has implemented a European Union directive that required all member states to align their standards on vision and driving by 2013.

All states needed to ensure that drivers applying for a licence, or the renewal of a licence, had a binocular visual acuity of at least 0.5.

"Driving not only affects you as a person but it affects the people around you"

UK optometrist and Association of Optometrists Councillor, Dr Julie-Anne Little, who led the drafting of the ECOO report, highlighted to OT that while countries met the broad thrust of the directive, many nations adopted different ways of implementing it.

"For example, in the UK we remain reliant on self-reporting and the driver self-testing with a number plate, whereas our closest neighbour Ireland requires drivers to attend a vision test and get a signed medical form determining their vision status before a driving licence application," she explained.

In the UK, a visual test is carried out by the driver testing officer, whereas in many European nations the vision assessment is carried out by an optometrist, ophthalmologist or medical doctor.

The ECOO report urged member states to ensure that visual standards for driving were assessed by an eye care professional and that sight testing was carried out as a requirement for licence renewal.

Optometrists have the right skills to take on this role, Dr Little explained, adding: "An optometrist's job is to understand, and try to maximise, people's vision and visual performance.

Optometrists are probably best-placed to give a judgement on visual function for everyday life.

There are significant differences in methods used to test vision across UK and Europe. In contrast to the UK's number plate test, drivers in other countries must take a series of visual acuity and visual field tests. In several countries, drivers attend a government driving centre for a medical and vision check ahead of licensing. In Belgium, there are additional tests that measure an individual's twilight vision and in Bulgaria, a driver's colour vision is assessed.

After a motorist has secured their licence in the UK, there is no regulatory requirement for a driver to have their vision tested again over the life of their licence. But in other countries, such as Italy, Spain and Bulgaria, visual tests are carried out every decade to ensure that a driver's vision is still safe for the road.

Visual testing in some countries increases in frequency as a driver ages, acknowledging the higher incidence of vision problems among older motorists.

The ECOO report called for a standardised visual acuity assessment across Europe and the UK and emphasised that the number plate test was not an adequate measure of visual acuity.

As part of its call to action, ECOO also urged member states to promote the effective assessment of vision, visual fields, contrast sensitivity and twilight vision. It was important that countries clarified what each test involved to avoid discrepancy between member states, the report emphasised.

"The vast majority of the time we are giving out good news - we are helping people to be able to drive and meet the standard"

Whatever change was implemented around vision and driving, it was important that optometrists give the public a positive message, Dr Little emphasised.

"As optometrists, we have all experienced people who are a bit nervous about coming in for a sight test or who have avoided it for a long time because they are worried about what the outcome might be," she elaborated.

"The vast majority of the time we are giving out good news - we are helping people to be able to drive and meet the standard," Dr Little concluded.

Image credit: Laurence Derbyshire

Read the original post:
Driving for change - AOP

Read More...

Diabetes camp educates, entertains – Hastings Tribune

June 16th, 2017 5:50 pm

Sometimes its good to just be one of the gang.

This is certainly true for those dealing with Type 1 diabetes. And thats why Camp Hot Shots has become a favorite get-away destination for hundreds of youngsters ages 6-12 in central Nebraska since 2001.

Founded by Mary Lanning Heathcare and presented this year in partnership with Grace United Methodist Church, the two-day camp gives youngsters dealing with the disease a chance to bond with fellow diabetics without having to address those intrusive questions so often posed by their well-meaning but unmindful peers.

DeAnn Carpenter, program coordinator for Mary Lannings diabetes program, said the camp which is funded in part through donations from area organizations combines diabetes education and a host of fun activities to create an experience many campers have come to look forward to year after year.

More than 20 area children are taking part in this years long list of camp activities, which include: Boat rides and water play at Lake Hastings and Aquacourt Water Park, YMCA play, string art, balloon artist/magician Poppin Penelope, taekwondo, and more.

Its just a time for kids who have Type 1 diabetes to come together and realize theyre not alone, Carpenter said. A lot of them are the only ones in their school system or community who have Type 1 diabetes and maybe feel a little alone, having to take care of themselves. Its a time to bond and interact with people who have the same diagnosis as them.

For many campers, the camp has become an annual tradition, a place to bond with new found friends over shared activities. In some instances, it may be the only contact they have with their fellow diabetic companions each year.

For Braden Benjamin, 12, of Friend, this year marks his seventh go-around in the camp.

I like coming to the lake and swimming and tubing with my friends, he said. I get to see other diabetics that Im not around very often. I know most of them, but there are a few new ones every now and then.

I also like going to the YMCA. They have a bunch of different activities, like tennis and racquetball. You can go to the batting cage, and theres a pool there, too.

But its the camaraderie with fellow diabetics that makes the camp experience special to himself and fellow participants, he said.

The camp allows me to talk to other diabetics that I dont get to see very often. Its just nice to be around other people who share the disease that you have and know what it feels like. I hope to make more friends at the camp this year and get better at taking care of my diabetes. If my blood sugars are good I can pretty much do anything if I treat it beforehand.

Kordell Lovitt, 13, of Chapel, is attending the camp for the fourth straight year. Like most all of his fellow campers, he considers the lake activities the high water point of the two-day outing.

Im just swimming and having fun with my friends that I dont see a lot, he said. We talk about how we take care of our diabetes and how we treat our lows and highs. It (diabetes) is kind of stressful, but sometimes I just get over it.

And camp is a big reason for that, he said.

The others tell me what I dont do right and that I can do a better job of it, he said. I check on my blood sugars often here to keep them in range.

Having to explain himself and his limitations to non-diabetics day in and day out makes coming to camp seem even more of a getaway experience each year.

When people ask me, Why do you have to do this? its kind of weird and awkward, he said. Here, I dont have to tell them anything. I just want to have fun and pay attention to my diabetes.

Fourth-time camper Emmilly Berglund, 12, of Shelton said she felt right at home navigating the lakeside waters with friends of a feather.

I just like to come and see the other kids and talk to them about how everything is, she said. Its just enjoyable and relaxing to hang around other kids who have it (Type 1 diabetes). Im looking forward to the new activities they have this year like string art and going to the water park and learning new things.

Lee Wigert, 65, is a teacher at Hastings College and pastor of United Methodist churches in Juniata, Holstein and Kenesaw.

He, along with his wife, Diane, and son, Nate, 32, who has diabetes, have been donating their time giving boat and jet ski rides and sharing their back yard abutting Lake Hastings for the past decade.

Its just amazing the bonding experience that these children have, he said. The kids come back year after year and call you by name and you remember them. I spend about three days getting the house ready and tubes and trampoline blown up.

We make sure everybody gets on the boat. What they take away from this is that they know the adults care for them and are here to help them out.

Visit link:
Diabetes camp educates, entertains - Hastings Tribune

Read More...

Study: Broccoli extract lowers blood sugar for type 2 diabetes patients – Atlanta Journal Constitution

June 16th, 2017 5:50 pm

Heres another reason to eat your greens.

A powder containing a chemical found in broccoli sprouts is capable of lowering blood sugar levels of persons with type 2 diabetes, according to a study published Wednesday byScience Transitional Medicine.

The powder contains a highly concentrated dose of sulforaphane, according to study co-author Anders Rosengren of the University of Gothenburg in Sweden.

Were very excited about the effects weve seen and are eager to bring the extract to patients, Rosengren toldNew Scientist.We saw a reduction of glucose of about 10 percent, which is sufficient to reduce complications in the eyes, kidneys and blood.

Rosengren and his colleagues conducted a 12-week experiment, with 97 people with type 2 diabetes taking either the sulforaphane powder or a placebo, The Scientist reported. Most of the participants continued to take metformin, a drug used to lower blood sugar levels in diabetics.

Rosengrens team discovered that the broccoli extract was able to reduce the participants blood glucose level by 10 percent compared to those who took the placebo, The Scientist reported.

More research is needed to see if this repurposed drug can be used to treat type 2 diabetes, as it was only tested in a small number of people and only helped a subset of those who are taking it, said Elizabeth Robertson, director of research atDiabetes UK. She told New Scientist thatfor now, we recommend that people continue with the treatment prescribed by their healthcare team.

Read this article:
Study: Broccoli extract lowers blood sugar for type 2 diabetes patients - Atlanta Journal Constitution

Read More...

Expand coverage for diabetes treatment | Sally Hillerich Galla – The Courier-Journal

June 16th, 2017 5:50 pm

Sally Hillerich Galla, Guest Contributor 3:13 p.m. ET June 15, 2017

Measuring blood sugar(Photo: Maya23K, Getty Images/iStockphoto)

It might be old-fashioned, but as a young child growing up in Kentucky, I was taught never to reveal my age. Yet to understand my story, you have to start with a number: Im 65, and Im incredibly fortunate to be alive.

At the age of 24, my doctor gave me six months to live, along with one last hope: an emergency surgery to treat the endometriosis which was threatening my life. Thankfully, that surgery was a success.

But my medical journey was just beginning.

In the weeks after my surgery, I lost 30 pounds, and my vision was getting increasingly blurry. A trip back to my doctor confirmed a new, equally troubling and unrelated diagnosis: Type-1 diabetes. At the time, the outlook for Type-1 patients was grim.

Like every person with Type-1 Diabetes, not a day goes by that I dont spend thinking about and treating my disease. But there are some risk factors beyond our control, notably that Medicare, unlike nearly every private insurance plan, wont pay for some treatments that helpus stay healthy.

To start, it helps to understand that Type-1 Diabetes keeps your pancreas from producing insulin, so those of us living with the disease must inject the right amount of insulin ourselves, using everything from needles to traditional insulin pumps. Youve probably seen these pumps; a patch is connected by tubes to a device clipped to your belt or placed in your pocket.

More: New health bill even worse threat for Kentuckians | Comment

More: Poverty, obesity fuel Ky's diabetes epidemic

More: Help list: Learn to avoid or manage diabetes

Devices like this come with significant drawbacks. They cant get wet, and patients with neuropathy and arthritis have a hard time connecting and re-connecting the tubes multiple times a day. However, they do have one major benefit: theyre covered by Medicare.

The device I use called an Omnipod isnt.

My Omnipod is a wireless pump; a small pod that can be worn nearly anywhere and is connected wirelessly to a device about the size of a cell phone, which doesnt have to be clipped to your clothing. Instead, it just has to be close by.

And this is where that bureaucratic thinking comes in. All other insulin pumps are paid for under Medicare Part B because theyre considered durable medical equipment.

But the Omnipod isnt.

Thats because the Omnipod is different. Each of the pods lasts three days. Once its supply of insulin is used up, you replace it with another. You keep the cell phone-sized transmitter, which connects wirelessly to each new pod. Yet even though it has been approved by the FDA for 12 years, Medicare still wont cover it.

Medicares non-coverage policy is in conflict with Congresss intent, which was to promote medical innovation. Back in 2003, they passed the Medicare Modernization Act, which made it clear: new technologies not covered under Part B should be covered under Part D, which covers medicines. Medicare hasnt used that authority to cover the Omnipod either. But it should.

Because Omnipod isnt covered under Medicare, the Federal government is forcing seniors like me to abandon the treatment we need.

Now Im fortunate: After paying out of pocket since I turned 65, I recently found out that my Express Scripts Medicare Advantage plan has decided to stop mirroring Medicares policy. Thanks to that decision, I will get the coverage I need. But millions of people arent as fortunate they rely on other Medicare and Medicare Advantage plans where Omnipod still isnt covered.

Every major diabetes patient and medical advocacy group agrees: There should be no reason why the Omnipod remains the only FDA-approved insulin pump not covered by Medicare. Theyve urged the Centers for Medicare and Medicaid Services to cover the Omnipod. And Im urging them now, too.

Medicare should cover Omnipod, because it is a critical part of my medical plan. I shouldnt be forced to lose it just because Ive turned 65and neither should any other senior.

A small business owner, Sally Hillerich Galla is a 40-year veteran of the health insurance industry who lives in Eastern Jefferson County with her husband, Patrick.

Read or Share this story: http://www.courier-journal.com/story/opinion/contributors/2017/06/15/expand-coverage-diabetes-treatment-sally-hillerich-galla/399244001/

Excerpt from:
Expand coverage for diabetes treatment | Sally Hillerich Galla - The Courier-Journal

Read More...

Honig family planning diabetes fundraiser – Napa Valley Register

June 16th, 2017 5:50 pm

This August, Stephanie and Michael Honig of Honig Vineyard and Winery will host a special party on their property in Rutherford to raise money for a nonprofit diabetes organization called Beyond Type 1.

The party at Honig is just one stop on an epic, 10-week adventure for Team Bike Beyond, a cycling team composed of 20 international riders living with Type 1 diabetes. As they pedal their way from New York City to San Francisco, they will spread the word about Type 1 while showing the world what it means to live Beyond Type 1.

The event, 6 p.m., Wednesday, Aug. 9 at Honig Vineyard and Winery will raise money and awareness for Type 1 Diabetes.

Musician Nick Jonas, Juliet de Baubigny, Sarah Lucas and Sam Talbot founded Beyond Type 1 in 2015, and 100 percent of every dollar raised directly supports the most promising global efforts and programs working to educate, advocate and cure Type 1 diabetes.

Type 1, which affects more than 420 million people globally, is an autoimmune disease that can happen to anyone, can present at any age, and is not related to diet or lifestyle. The Honigs oldest daughter, Sophia, who recently turned 10, was diagnosed with Type 1 at the age of 5, changing the family dynamic forever.

No parent should ever be told that their child has a life-threatening, incurable disease. We will continue to do everything in our power until a cure is found, said Stephanie Honig.

Rep. Mike Thompson said, The Honigs have been tireless advocates for Sophia and the millions of other children and families living with Type 1 diabetes. Their efforts are more important than ever as federal funding for medical research comes under attack.

On the afternoon of the event, the Napa County Sheriffs Office, along with county officials, will escort and welcome the 20 bike riders into Napa County.

There are 11 restaurants hosting food stations: Brasswood, Brix Restaurant, Charlie Palmer, The Cliff Familys Bruschetteria, Crisp Kitchen and Juice, Elaine Bell Catering, Heritage Eats, Model Bakery, Mustards Grill, Oakville Grocery and Prabh Indian Kitchen.

Wine will be provided by Honig Vineyard and Winery, Beran, Dutch Henry, Jordan, Luna, St. Supery and Vineyard 29, with cocktails from Charbay. Music for the event will be provided by Groovetronix Productions. Classic Party Rentals is donating all of the party equipment, furnishing and supplies.

Sponsors of this event include Darioush, Trinchero Family Estates, Breakthrough Beverage Group, Chuck Wagner from Caymus Family Wines, David Drucker from Empire Merchants, St Helena Hospital, The Rudd Foundation, American AgCredit, Jelly Belly Candy Company, Jamie Kurtzig and Family, Nomacorc/Vinventions.

For more information, contact stephanie@honigwine.com or visit https://beyondtype1.org/event/bike-beyond-party-napa-valley-california/.

See the original post here:
Honig family planning diabetes fundraiser - Napa Valley Register

Read More...

Book World: The brutal blindness of Jim Crow justice in 1957 Alabama – Laredo Morning Times

June 16th, 2017 5:47 pm

Photo: Liveright, Handout

He Calls Me by Lightning: The Life of Caliph Washington and the Forgotten Saga of Jim Crow, Southern Justice, and the Death Penalty

He Calls Me by Lightning: The Life of Caliph Washington and the Forgotten Saga of Jim Crow, Southern Justice, and the Death Penalty

Book World: The brutal blindness of Jim Crow justice in 1957 Alabama

He Calls Me by Lightning: The Life of Caliph Washington and the Forgotten Saga of Jim Crow, Southern Justice, and the Death Penalty

By S. Jonathan Bass

Liveright. 413 pp. $26.95

---

How is it possible in a country that prides itself on having a Bill of Rights, expresses reverence for due process and touts equal protection that a 17-year-old can be arrested, put on trial and sentenced to death, and then spend 13 years being shuttled among death row cellblocks in disgusting jails and prisons with his case under appeal, all for a crime he didn't commit?

The answer contains some simple prerequisites: He had to be black, live in the Jim Crow South and be accused of committing, as one deputy sheriff put it, a "supreme offense, on the same level of a white woman being raped by a black man" - that is, the murder of a white police officer.

Teenager Caliph Washington, a native of Bessemer, Ala., was on the receiving end of all three conditions. And as such, Washington became a sure-fire candidate to suffer the kind of tyrannical law enforcement and rotten jurisprudence that Southern justice reserved for blacks of any age.

In "He Calls Me by Lightning," S. Jonathan Bass, a professor at Alabama's Samford University and a son of Bessemer parents, resurrects the life of Washington, who died in 2001 finally out of prison - but with charges still hanging over his head.

Bass, however, does more than tell Washington's tale, as Washington's widow, Christine, had asked him to do in a phone call. Bass dives deeply into the Bessemer society of 1957 where Washington was accused of shooting white police officer James "Cowboy" Clark on an empty dead-end street near a row of run-down houses on unpaved Exeter Alley.

Bessemer-style justice cannot be known, let alone understood, however, without learning about that neo-hardscrabble town 13 miles southwest of Birmingham.

Bessemer served as home to a sizable black majority, an entrenched white power structure and an all-white police department, consisting at the time of a "ragtag crew of poorly paid, ill-trained, and hot-tempered individuals" who earned less than Bessemer's street and sanitation workers.

Bessemer was a town with its own quaint racial customs, such as forcing black men to "walk in the middle of the downtown streets, not on the sidewalks, after dark - presumably to keep them from any close contact with white women."

Bessemer was a town where in 1944 the police forced black prisoners to participate in an Independence Day watermelon run. White citizens reportedly cheered as firefighters blasted the inmates with high-pressure hoses to make the race more challenging. Winners, it is said, received reduced sentences and the watermelons.

It was in that town that Caliph Washington was born in 1939, the same year of my birth in Washington, D.C.

Bessemer's racial climate was no different the year Washington was accused of killing Cowboy Clark. The town's prevailing attitude on race was captured at the time in a pamphlet distributed by a segregationist group, the Bessemer Citizens' Council. Black Christians, the white citizens' council said, should remain content with being "our brothers in Christ without also wanting to become our brothers-in-law."

If ever there was a place to not get caught "driving while black" - which is what Washington was doing on that fateful night in July 1957 - it was Bessemer. And that night's hazard appeared in the form of Clark and his partner, Thurman Avery, who were cruising the streets in their patrol car looking for whiskey bootleggers.

Washington was not one.

But his color was enough to get him chased, pulled over and told by Clark to "get out, boy."

Washington's color was enough to cause Cowboy to instruct him to place his hands over his head, to get him patted down and escorted to the rear of Cowboy's patrol car, where a tussle ensued following Cowboy's accusation that Washington had whiskey in his car; Washington's denial; Cowboy calling Washington a "smart n-----"; and Cowboy getting so angry that he pulled his weapon and started to strike Washington in the head with the butt of the gun.

Three shots went off in rapid succession - the prosecution said Washington pulled the trigger; Washington's defense said the bullet that ripped through Cowboy resulted from an accidental discharge - that it hit the car, ricocheted and tore into Cowboy.

Both sides agreed on one thing: Washington ran off.

It was a dash compelled by fear and a Southern-bred instinct that no good comes to a black man who defends himself against a white man.

Next, a massive manhunt, arrest in Mississippi, return to Bessemer courthouse, angry cursing white cops, lots of guns, plenty of hate and a jury decidedly not of Washington's peers.

Washington, accused of committing a crime against a white man in Bessemer, Ala., entered a courtroom to face a white prosecutor, a white judge and an all-white jury. To have a black lawyer defend Washington in 1957, Bass observes, would have been seen as an affront to Southern traditions.

Bessemer had only one black lawyer: David Hood Jr., a Howard University Law School graduate. Hood and another black lawyer, a fellow Howard graduate, Orzell Billingsley Jr. of Birmingham, helped prepare Washington's case for trial.

But they knew what Bass would later write in his book: that white supremacy and racial superiority were so deeply ingrained, Bessemer in 1957 was no place or time for a black lawyer to defend a black man. So, to represent Washington, the court appointed a white lawyer, giving him 14 days to prepare for the murder trial.

It was the start of a legal proceeding that stretched more than 13 years - a trek that, along the way, found countless opportunities to celebrate the triumph of racial traditions over justice.

Washington endured police interrogations without counsel; denial of the right to cross-examine witnesses; years of confinement behind bars without trial; more than a dozen scheduled dates with the electric chair, relieved by last-minute reprieves; blatantly discriminatory jury selections; and often languid and lukewarm efforts by the defense bar.

One notable exception in Bass' recitation of Alabama judicial horrors is the role played by Gov. George Wallace. Morally opposed to the death penalty, Wallace granted Washington 13 stays of execution. But Wallace's opposition wasn't enough to stop him from letting other prisoners be put to death, and the governor denied Washington's 14th petition for a reprieve.

I stop short of Bass' sympathetic portrayal of Wallace.

It fell to federal Judge Frank M. Johnson Jr., a law school classmate and onetime friend of Wallace, to render justice. Johnson, not Wallace, stayed Washington's execution. Johnson, not Wallace, recognized errors in the trial that found Washington guilty. Johnson, not Wallace, ordered Washington's conviction and death sentence be set aside. It was Johnson, not the racially demagogic Wallace, who redeemed what little there was left of integrity in Alabama jurisprudence and set Washington free to live what was left of his life. And out of America's sight.

In sharper focus, thanks to Bass' painstaking research, is a picture of how Jim Crow legal systems operated at the local and state levels. Because of his diligent examination of the backgrounds, upbringing and pedigree of those white Southern men and women who enforced Deep South justice, we know more about how courtrooms and jails functioned, and how cops, lawyers, courts and juries combined to degrade the judicial system. Bass provides details, details and more details, to the point, at times, of being overdone.

There is much in "He Calls Me by Lightning" that we needed to know. There is much, almost too much, in this book that is simply nice to know. But we are left, at the last page, with insight into a history of America that can no longer be left unknown.

---

King, winner of the 2003 Pulitzer Prize for commentary, joined the editorial board of The Washington Post in August 1990 and was deputy editorial page editor from January 2000 until his retirement in 2007. He continues to write a weekly column.

See the original post:
Book World: The brutal blindness of Jim Crow justice in 1957 Alabama - Laredo Morning Times

Read More...

Willful Blindness Costs Dish Network $341000000 For TCPA Violations – Lexology (registration)

June 16th, 2017 5:47 pm

Willful blindness when it comes to the Telephone Consumer Protection Act (TCPA) could cost companies millions in statutory damages and penalties. Dish Network has been ordered in two cases to pay a total of $341 million based on its failure to prevent TCPA violations committed by its marketing agents. The cases illustrate the factors that courts may consider in determining what level of culpability is appropriate for ignoring TCPA violations, even in the absence of direct knowledge.

In Krakauer v. Dish Network LLC, 14-333 (M.D.N.C. May 22, 2017), the court rejected Dish Networks claims that it sufficiently supervised its marketing agent, Satellite Systems Network (SSN), to prevent SSN from making unsolicited calls to consumers. According to the court, treble damages were appropriate because (1) SSN knowingly violated the statute, and (2) Dish Network turned a blind eye to SSNs TCPA violations. The ruling contributes to the uncertainty regarding when courts will find a TCPA violation to be willful and thus subject to treble damages.

In US v. Dish Network, LLC, No. 09-3073 (C.D. Ill. June 5, 2017), the court found that a mathematical calculation of statutory damages would be disproportionate and unreasonable, and therefore did not award treble damages. The court did find, however, that a large civil penalty was appropriate after considering the degree of Dish Networks culpability, its history of prior conduct, its ability to pay and other circumstances.

The TCPA provides for $500 in statutory damages per violation. Courts have discretion to award treble damages for willing or knowing violations. In recent cases, courts have applied varying standards to determine whether conduct is willful and thus subject to treble damages. Some courts have required that the defendant have direct knowledge of calls made and knowledge that the calls violate the TCPA. For example, in Lary v. Trinity Phys. Fin. & Ins. Servs., 780 F.3d 1101 (11th Cir. 2015), the court found that it was not enough to require only that the alleged violator know that it was engaging in the conduct; instead the violator must also know that the conduct violates the TCPA, [otherwise] the statute would have almost no room for violations that are not willful or knowing. The Lary court also noted that the defendants in that case could not be responsible for treble damages under the TCPAs willful and knowing requirement since the defendants had used a third party to send out advertisements, which suggests that [the defendants] might have had no knowledge that [the plaintiff] received a particular fax. See also Harris v. World Fin. Network Natl Bank, 867 F. Supp. 2d 888, 895 (E.D. Mich. 2012) (observing that an overbroad application of willfulness would significantly diminish the statutes distinction between violations that do not require an intent, and those willful and knowing violations that Congress intended to punish more severely.); Brown v. Enter. Recovery Sys., Inc., 2013 WL 4506582, at *9 (Tex. App. Aug. 22, 2013) (But to recover treble damages, the Browns had to show that ERS knew of the TCPAs requirements and that it knew or should have known that its actions violated the Act.).

In some cases, however, courts have stated that treble damages could be awarded where there was only intent to perform the conduct at issue, regardless of whether the defendant knew that the conduct violated the TCPA. In Clark v. Red Rose, Mentor M.C. No. 04CVF-150, 2004 WL 1146679 (May 3, 2004), a consumer brought an action against Red Rose claiming that the company sent her unsolicited fax advertisements. The court awarded treble damages and noted that, as defined in the Federal Communications Act, the term willfully merely means that the defendant acted voluntarily, and under its own free will, and regardless whether the defendant knew that it was acting in violation of the statute. Regarding the knowing standard, the court explained that [k]nowingly may not be held to mean that the defendant must know that its acts were a violation of the law, since this would conflict with the long-established legal principle that ignorance of the law is no excuse. See also American Home Servs., Inc. v. A Fast Sign Co., Inc., 747 S.E.2d 205, 208-209 (Ga. App. 2013) (AHS admitted that it hired Sunbelt to send advertising faxes on its behalf. This is sufficient to make the violation willful within the meaning of the statute.).

Dish Network, a telecommunications service provider, was sued in 2014 in a class action after its marketing agent, SSN, was accused of making more than 50,000 telemarketing calls on Dishs behalf to numbers on the National Do-Not-Call Registry. The lead plaintiff, Dr. Thomas Krakauer, sought injunctive and monetary relief on behalf of himself and others who had allegedly received the calls. Following trial, the jury found Dish Network liable and awarded $20.5 million in damages. The parties then submitted closing arguments to the court on whether the TCPA violations were willful for purposes of treble damages, which was the subject of the courts May 22 opinion.

The court held that Dish Network willfully and knowingly violated the TCPA and trebled the damages award to $61 million. Although SSN made the calls, the court reasoned that Dish, as the principal, was vicariously liable. The court also explained that certain aggravating factors justified the award of treble damages. First, Dish Network failed to monitor SSNs calling practices, ignored SSNs many TCPA violations over the years, and repeatedly looked the other way. Second, and even more damaging, the court was convinced that Dish Network did not care whether SSN complied with the law or not and that Dish Networks TCPA compliance policy was decidedly two-faced, allowing Dish Network to monitor TCPA compliance while Dish Network failed to do so.

Dish Network is expected to appeal the district courts ruling to the US Court of Appeals for the Fourth Circuit, especially considering the inconsistent standards for awarding treble damages and Dish Networks position that the company did all it could to ensure SSN was in compliance with the TCPA. In the meantime, the ruling adds more concern for defendants on the possibility of treble damages and creates another big-dollar TCPA headline.

Unlike the court in Krakauer, the district court judge in US v. Dish Network, LLC, No. 09-3073 (C.D. Ill. June 5, 2017) decided against statutory damages, which the court found unreasonable and disproportionately high given that such damages totaled in the billions of dollars. The court, therefore, did not consider treble damages. Instead, the court awarded a $280 million civil penalty, citing Dishs culpability, its history of prior conduct, its ability to pay and other circumstances. The court found that culpability was significant because the programs were run in a reckless manner. According to the court, Dish [Network] had on-going problems complying with Do-Not-Call Lawsand understood the potential penalties for Do-Not-Call Law violations could be substantial, and yet the problems persisted over many years. Similar to Krakauer, the court was troubled that Dish Network seemed to make little effort to comply with the TCPA, noting, for example, that Dish Network hired Order Entry Retailers based on one factor, the ability to generate activations and that Dish [Network] cared about very little else, including complying with Do-Not-Call laws.

Companies concerned about avoiding potential TCPA exposure should be aware of the factors that some courts have considered in deciding what level of damages and/or penalties are appropriate:

The TCPA continues to create significant litigation risk for any company that communicates with customers or potential customers by phone, text or fax. Although the potential for treble damages and heavy civil penalties heightens the risk, efforts to put strong compliance procedures in place can not only reduce the risk of lawsuits, but also reduce the risk of treble damages in the event of litigation.

Go here to see the original:
Willful Blindness Costs Dish Network $341000000 For TCPA Violations - Lexology (registration)

Read More...

ASA Provides Input to USDA, FDA on Advances in Biotechnology – KTIC

June 16th, 2017 5:47 pm

The American Soybean Association (ASA) submitted comments this week to both the U.S. Department of Agriculture (USDA) and the U.S. Food and Drug Administration (FDA) regarding regulations in response to advances in genetic engineering.

ASA included in comments to USDA, that biotechnology is an essential tool in farmers quest to produce enough food to meet the needs of 9.7 billion people by 2050, creating the need for a clear, science-based regulatory system in the U.S. as an example and standard for regulatory systems of biotechnology internationally.

While applauding USDAs efforts to reduce the burden on regulated entities, ASA expressed concern that aspects of the rule as proposed will increase the regulatory burden and stifle research and innovation.

Additionally, ASAs comments to FDA cheered USDAs proposal to exclude certain genome-editing techniques from requiring pre-market approvals because they are low risk and could be found in nature or achieved through traditional breeding methods.

ASA concluded its support saying, Technological advancements such as genome editing offer an additional tool to combat threats while also improving sustainability in production agriculture.

Full comments to USDA and FDA can be found here and here, respectively.

Read the original:
ASA Provides Input to USDA, FDA on Advances in Biotechnology - KTIC

Read More...

$10M for birthplace of biotechnology – Innovators Magazine

June 16th, 2017 5:47 pm

(CALIFORNIA)

Thebirthplace of biotechnology is to receive$10 million for a pioneering precision medicine programme.

It was announced this week thatthe California Initiative to Advance Precision Medicine (CIAPM) has been awarded the money from the local governments budget, a decision welcomed by theCalifornia Life Sciences Association (CLSA).

Sara Radcliffe, President & CEO, CLSA, said:California Life Sciences Association (CLSA) applauds Governor Jerry Brown, California State Senate and California Assembly leaders for their strong support of life sciences innovation, as demonstrated again in this years 2017-2018 budget deal which allocates a $10 million investment in precision medicine research. California is the birthplace of biotechnology and today the states life sciences sector employs over 287,200 people working to develop innovative new medicines, technologies and therapies needed to treat and cure patients.

The Californian city of San Diego ishostingtheBIO International Conventionalthe global event for biotechnology next week. It will celebrate the industrys many breakthroughs and on going impact on society.It will take place at the San Diego Convention Center between 19 and 22 June.

BIO International ConventionalCalifornia Initiative to Advance Precision Medicine

Visit link:
$10M for birthplace of biotechnology - Innovators Magazine

Read More...

FBI says Chinese spying, theft of US agricultural biotechnology is ‘a growing threat’ – Genetic Literacy Project

June 16th, 2017 5:47 pm

As a group of visiting scientists prepared to board a plane in Hawaii that would take them back home to China, U.S. customs agents found rice seeds in their luggage. Those seeds are likely to land at least one scientist in federal prison.

Agriculture today is a high-tech business, but as that technology has developed, so has the temptation to take shortcuts and steal trade secrets that could unlock huge profits. The FBI calls agricultural economic espionage a growing threat and some are worried that biotech piracy can spell big trouble for a dynamic and growing U.S. industry.

Had they succeeded in stealing the gene-spliced rice, the scientists may have been able to reverse-engineer it and ultimately undercut [US company] Ventrias market. [Ventria President and CEO Scott] Deeter says it could have driven his company out of business.

Where the commodity in question is grown in open fields, its sometimes difficult, [Jason] Griess [the assistant U.S. attorney for the Southern District of Iowa] says.

Theft of intellectual property costs the U.S. economy hundreds of billions of dollars each year, according to a recent report from the Commission on the Theft of American Intellectual Property, a Washington, D.C.-based ad-hoc panel formed to study intellectual property theft. China, the authors say, is the biggest offender.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post:Spies In The Field: As Farming Goes High-Tech, Espionage Threat Grows

Read more:
FBI says Chinese spying, theft of US agricultural biotechnology is 'a growing threat' - Genetic Literacy Project

Read More...

New effective treatments for psoriatic arthritis patients – Medical Xpress – Medical Xpress

June 16th, 2017 5:46 pm

June 16, 2017

The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference revealed promising data supporting two new drug classes for the treatment of psoriatic arthritis (PsA).

New agents working on different inflammatory aspects of PsA are needed in the treatment of PsA patients living with this chronic immune-mediated disease, which involves both joint and skin symptoms.

In the first study, in patients with active PsA who had not previously been prescribed an anti-TNF treatment, tofacitinib (an oral Janus kinase inhibitor under investigation for the treatment of PsA), was superior to placebo in ACR20 response rates and change from baseline in the HAQ-DI score at 3 months. Tofacitinib demonstrated superiority to placebo as early as week 2, and this was maintained for 12 months. No new safety risks were identified compared to previous studies in other indications.1

In the second study, in patients with active PsA and 3% or more of their body surface area affected by plaque psoriasis despite current or previous treatment with standard-of-care therapies, including anti-TNF treatments, guselkumab demonstrated significant improvement in joint symptoms, physical function, psoriasis, enthesitis , dactylitis and quality of life. Guselkumab, a fully human monoclonal antibody targeting IL-23, in this Phase 2 study for the treatment of PsA, was well tolerated with no unexpected safety findings in this patient population.2 Guselkumab is now being pursued in a Phase 3 development programme for psoriatic arthritis.

Tofacitinib Phase 3 Results positive for treating PsA

At month 3, tofacitinib 5 and 10 mg twice-daily showed a statistically significant improvement compared to placebo as measured by the ACR20 response (p?0.05 and p<0.0001 respectively), and change from baseline in the HAQ-DI score (p?0.05 and p<0.001).

"Despite the differences emerging in the pathophysiology of PsA and rheumatoid arthritis, tofacitinib, which works on many different cytokines, shows efficacy in the treatment of both conditions," said lead author Professor Philip J. Mease from the Swedish-Providence St. Joseph Health Systems and University of Washington School of Medicine, Seattle, US. "Since tofacitinib is a tablet and not an injection, once it receives regulatory approval, it is likely to be popular with both physicians and patients," he added.

Tofacitinib 5 and 10 mg twice-daily was superior to placebo for ACR20 response rates at week 2 (p<0.001 and p<0.0001 respectively) with responses maintained to 12 months. Greater efficacy was also seen for adalimumab vs. placebo.

More than 91% of patients were radiographic non-progressors at 12 months. Safety findings were similar between the treatment groups at 12 months. The most common adverse events were upper respiratory tract infection (7.5-10.6%), nasopharyngitis (7.5-11.5%) and headache (3.8-10.6%).

Eligible patients in this randomised, placebo- and active-controlled, 12-month Phase 3 trial had a PsA diagnosis for at least 6 months, fulfilled CASPAR criteria , had active arthritis (at least 3 tender/painful and at least 3 swollen joints) and active plaque psoriasis at screening, inadequate response to at least 1 csDMARD , and were tumour necrosis factor-inhibitor (TNFi)-nave.

422 patients were randomised 2:2:2:1:1 to tofacitinib 5 or 10 mg twice daily, adalimumab 40 mg subcutaneous injection every 2 weeks, or placebo (advancing to tofacitinib 5 or 10 mg twice-daily at 3 months). Stable treatment with 1 csDMARD was required. 96.9% of patients were white and 53.3% were female; mean age was 47.9 years. 96.2% and 88.4% of patients completed 3 and 12 months respectively.

Guselkumab improved PsA symptoms, physical function and quality of life

In this Phase 2a study, significantly more guselkumab-treated patients achieved ACR 20/50/70 responses and Psoriasis Area Severity Index (PASI) 75/90/100 responses at week 24. Nearly 40% of patients in the active group, vs. 6.3% in the placebo arm, achieved PASI 100 (completely clear skin) at week 24.

"Guselkumab, which targets IL-23, appears to be a promising new treatment of PsA," said lead author Professor Atul Deodhar from Oregon Health & Science University, Portland, US. "Although anti-TNF treatments have revolutionised the management of psoriatic arthritis, new next-generation therapies are needed in the treatment of this disease," he added.

As early as 4 weeks into treatment, 21% in the guselkumab group had a significant treatment effect on ACR20 response, compared to zero in the placebo group (p<0.001). The ACR response in the active arm increased with time, with 58% of subjects reaching a 20% improvement in joint symptoms at week 24, versus 18.4% of those on placebo (p<0.001). Fourteen percent of patients on guselkumab achieved ACR70, versus 2% on placebo, at week 24 (p=0.023).

Resolved enthesitis occurred in 29.0% of those patients with enthesitis at baseline in the placebo group at week 24, versus 56.6% on guselkumab (p=0.012). The percentage resolution from baseline to week 24 for dactylitis (in those patients with dactylitis at baseline) was 17.4% of patients on placebo, versus 55.2% on guselkumab (p<0.001). And the percentage of patients achieving minimal disease activity at week 24 was 2% for placebo compared to 23% in the guselkumab group (p=0.001).

Patients in the active arm also seemed to experience mental benefits, with significantly higher scores on the SF-36 mental component summary (p=0.002), in addition to significantly higher physical component scores (p<0.001).

Guselkumab was well tolerated; through week 24, the proportion of patients with at least 1 adverse event was comparable between the two groups (guselkumab 36.0% vs. placebo 32.7%). Infections were the most common adverse events (guselkumab 17.0% vs. placebo 20.4%). The researchers reported no serious infections, cancer or death during the 24 weeks of the study.

This Phase 2a, randomised, double-blind, placebo-controlled multicentre study included 149 active PsA patients. Patients had psoriasis plaques covering three percent or more of their body surface area, despite standard-of-care treatment, which in some patients included anti-TNF agents. In a 2:1 ratio, patients received either 100 mg guselkumab given subcutaneously, or placebo at baseline and week four; then, every eight weeks through week 44.

Patients in both arms who had less than a 5 percent improvement from baseline in swollen and tender joint counts by week 16 could qualify for early escape and switch to open-label therapy with ustekinumab. All remaining placebo patients crossed over to the guselkumab arm at week 24.

Baseline demographics and ACR component measures were generally similar between the two groups. Four (8.2%) of the patients in the placebo group and 9 (9.0%) of patients in the guselkumab group had been previously exposed to an anti-TNF agent

Explore further: Tofacitinib ups rheumatoid arthritis treatment response

(HealthDay)The addition of tofacitinib to rheumatoid arthritis (RA) treatment regimens improves patient response to non-biologic disease-modifying antirheumatic drugs (DMARDs), according to a study published in the Aug. ...

A Phase 3 clinical trial demonstrates that tofacitinib improves disease activity and inhibits progression of joint damage in rheumatoid arthritis (RA) patients who did not respond to methotrexate (MTX). Results of the 12-month ...

The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference have highlighted limitations in the current treatment of patients with Psoriatic Arthritis (PsA).

New data presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism show that apremilast administered to patients with psoriatic arthritis continues to demonstrate meaningful clinical responses ...

Results of a Phase III study presented today at the EULAR 2011 Annual Congress show that at 6 months, 58.3 percent of patients who had previously not responded to treatment with DMARDs, achieved ACR20 response (a 20 percent ...

In a pivotal phase-3 clinical trial led by a Stanford University School of Medicine investigator, patients with psoriatic arthritis for whom standard-of-care pharmaceutical treatments have provided no lasting relief experienced ...

Stepping up to biologic therapy when methotrexate monotherapy fails offers minimal incremental benefit over using a combination of drugs known as triple therapy, yet incurs large costs for treating rheumatoid arthritis (RA). ...

New research from the University of Liverpool, published today in the journal npj Systems Biology and Applications, has identified 'cell messages' that could help identify the early stages of osteoarthritis (OA).

Osteoarthritis can potentially be prevented with a good diet and regular exercise, a new expert review published in the Nature Reviews Rheumatology reports.

Maintaining the supply of a molecule that helps to nourish cartilage prevented osteoarthritis in animal models of the disease, according to a report published in Nature Communications online May 11.

The results of a study led by Massachusetts General Hospital (MGH) investigators suggest that following a diet known to reduce the risk of hypertension and cardiovascular disease may also reduce the risk of gout. The team's ...

In a preclinical study in mice and human cells, researchers report that selectively removing old or 'senescent' cells from joints could stop and even reverse the progression of osteoarthritis.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Follow this link:
New effective treatments for psoriatic arthritis patients - Medical Xpress - Medical Xpress

Read More...

Music video about arthritis features Charcandrick West and 10-year-old singing partner – fox4kc.com

June 16th, 2017 5:46 pm

Please enable Javascript to watch this video

KANSAS CITY, Mo. --Charcandrick West, Chiefs running back, teamed up to make a music video with a little girl named Jillian Reid, age 10, because both of them have arthritis.

The music video is meant to raise awareness.

It features Charcandrick singing the song "Body of Steel". You can scroll down to watch and listen to the music video on YouTube.

Some of the lyrics:

We fight every day into the morning light We try to do the impossible. That's right. With every inch of pain, every scar.

One hand Holding onto another hand. One glance Telling me that I can try again and again. I know you got my back if I fall.

We can make it. Just look how far we've come. Everyday is a blessing...

Cause I got a body of steel I'm a fighter

One breath at a time One step at a time

More:
Music video about arthritis features Charcandrick West and 10-year-old singing partner - fox4kc.com

Read More...

Page 984«..1020..983984985986..9901,000..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick